<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Other disorders of glycogen metabolism: GLUT2 deficiency and aldolase A deficiency</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Other disorders of glycogen metabolism: GLUT2 deficiency and aldolase A deficiency</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Other disorders of glycogen metabolism: GLUT2 deficiency and aldolase A deficiency</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">William J Craigen, MD, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Basil T Darras, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sihoun Hahn, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elizabeth TePas, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 27, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Glycogen is the stored form of glucose and serves as a buffer for glucose needs. It is composed of long polymers of a 1,4-linked glucose, interrupted by a 1,6-linked branch point every 4 to 10 residues. Glycogen is formed in periods of dietary carbohydrate loading and broken down when glucose demand is high or dietary availability is low  (<a class="graphic graphic_figure graphicRef81164" href="/d/graphic/81164.html" rel="external">figure 1</a>).</p><p>There are a number of inborn errors of glycogen metabolism that result from mutations in genes for virtually all of the proteins involved in glycogen synthesis, degradation, or regulation  (<a class="graphic graphic_figure graphicRef81164" href="/d/graphic/81164.html" rel="external">figure 1</a>). Those disorders that result in abnormal storage of glycogen are known as glycogen storage diseases (GSDs)  (<a class="graphic graphic_table graphicRef54417" href="/d/graphic/54417.html" rel="external">table 1</a>).</p><p>Glycogen is most abundant in liver and muscle. The major manifestations of disorders of glycogen metabolism affecting the liver are hypoglycemia and hepatomegaly, and the primary features of those defects that affect muscle are muscle cramps, exercise intolerance, easy fatigability, and progressive weakness.</p><p>This topic will review two disorders of glycogen metabolism: glucose transporter 2 (GLUT2) deficiency and aldolase A deficiency. An overview of GSDs is presented separately. (See  <a class="medical medical_review" href="/d/html/2941.html" rel="external">"Overview of inherited disorders of glucose and glycogen metabolism"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">GLUT2 DEFICIENCY</span><span class="headingEndMark"> — </span>GLUT2 deficiency (MIM #227810), also known as Fanconi-Bickel syndrome, is a rare disorder of glucose homeostasis that leads to accumulation of glycogen in the liver and kidney and glucose and galactose intolerance. GLUT2 is a facilitative, bidirectional transporter. It passively transports intracellular glucose and galactose across the basolateral membrane of cells including hepatocytes, pancreatic beta cells, renal tubular cells, and intestinal epithelial cells by moving the carbohydrate molecule down its concentration gradient [<a href="#rid1">1</a>]. Transient expression of induced apical membrane GLUT2 plays a role separate from sodium-glucose transporter 1 (SGLT1 or SLC5A1) in the absorption of simple sugars in the intestinal mucosa and is a potential target for modulating carbohydrate absorption [<a href="#rid2">2</a>]. Glycogen accumulation in patients with GLUT2 deficiency occurs due to a failure to adequately export glucose generated by glycogen degradation. This inadequate export leads to a marked increase in intracellular glucose that inhibits glycogen degradation. (See  <a class="medical medical_review" href="/d/html/1785.html" rel="external">"Pancreatic beta cell function", section on 'Role of glucose'</a>.)</p><p class="headingAnchor" id="H3"><span class="h2">Genetics</span><span class="headingEndMark"> — </span>The disorder is due to pathogenic variants in the gene for the glucose transporter GLUT2 (solute carrier family 2 member 2 [<em>SLC2A2</em>]), located at 3q26 [<a href="#rid3">3</a>]. Inheritance is autosomal recessive. Many cases occur in consanguineous families [<a href="#rid4">4</a>].</p><p class="headingAnchor" id="H4"><span class="h2">Clinical features</span><span class="headingEndMark"> — </span>Affected patients typically present in infancy with hepatomegaly secondary to glycogen accumulation, severe failure to thrive, and rickets [<a href="#rid5">5</a>]. Neonatal diabetes, either transient or persistent, has also been observed. Patients have a characteristic tubular nephropathy, with glucosuria, phosphaturia, bicarbonate wasting, and a generalized amino aciduria, leading to rickets [<a href="#rid5">5,6</a>]. Osmotic diuresis leads to polyuria. Short stature persists through adulthood [<a href="#rid7">7</a>]. (See  <a class="medical medical_review" href="/d/html/5856.html" rel="external">"Overview of rickets in children"</a>.)</p><p>In a study of 104 neonates with diabetes in whom other genetic causes of neonatal diabetes had been excluded, five were found to have pathogenic variants in <em>SLC2A2</em> [<a href="#rid8">8</a>]. Aberrant hepatocyte glucose transport results in postprandial hyperglycemia followed by fasting hypoglycemia. Glucose-stimulated insulin release is diminished and contributes to poor glucose control. Hemoglobin A1c (HgbA1c) is normal, and fasting hypoglycemia and postprandial hyperglycemia appear to improve with age [<a href="#rid9">9</a>]. Another report described 10 patients with Fanconi-Bickel syndrome who presented with polyuria, polydipsia, hepatomegaly, rickets, and stunting at a median of five months [<a href="#rid10">10</a>]. Glucosuria, generalized aminoaciduria, beta-2-microglobinuria, urinary phosphate wasting, and hypercalciuria were present in all patients. In addition, three patients had nephrocalcinosis, and one had transient neonatal diabetes.</p><p>Intellectual development is normal in patients with GLUT2 deficiency. Linear growth and puberty are delayed. While the underlying mechanisms have not been well documented in GLUT2 deficiency, endocrine abnormalities have been documented in other forms of hepatic glycogenoses that may be operative in GLUT2 deficiency [<a href="#rid11">11</a>].</p><p>Clinical features of GLUT2 deficiency have considerable overlap with glycogen storage disease Ia (GSD Ia; glucose 6-phosphatase deficiency). However, severe hypoglycemia, lactic acidemia, and hyperuricemia are not present in GLUT2 deficiency, and renal tubulopathy is seen only in GLUT2 deficiency. Conversely, autosomal recessive proximal tubulopathy and hypercalciuria (ARPTH), which may present with hypophosphatemic rickets, is allelic with Fanconi-Bickel syndrome [<a href="#rid12">12</a>]. Reminiscent of GSD Ia, hepatocellular carcinoma was reported in a six-year-old affected child [<a href="#rid13">13</a>], and metanephric renal carcinoma was described in a 21-month-old child [<a href="#rid14">14</a>].</p><p class="headingAnchor" id="H5"><span class="h2">Diagnosis</span><span class="headingEndMark"> — </span>The diagnosis of GLUT2 deficiency should be considered in a child with the symptoms described plus altered glucose homeostasis, accumulation of glycogen in the liver, and a Fanconi-type tubulopathy. Tests of glucose and galactose tolerance and kidney function are abnormal. Serum biotinidase activity may be increased, as is observed in other GSDs [<a href="#rid15">15</a>]. Liver biopsy reveals increased glycogen content without significant inflammation or fibrosis. The diagnosis is confirmed by deoxyribonucleic acid (DNA) analysis. The disorder may be detected by a newborn screening test that is positive for galactosemia if the basis for screening is the direct measurement of galactose and not measurement of galactose-1-phosphate uridyl transferase (GALT) activity [<a href="#rid16">16</a>].</p><p class="headingAnchor" id="H6"><span class="h2">Treatment</span><span class="headingEndMark"> — </span>No specific treatment is available. Management of the kidney disease consists of supplementation of water and electrolytes, <a class="drug drug_general" data-topicid="10109" href="/d/drug information/10109.html" rel="external">L-carnitine supplements</a>, vitamin D supplements (<a class="drug drug_general" data-topicid="10150" href="/d/drug information/10150.html" rel="external">ergocalciferol</a> or <a class="drug drug_general" data-topicid="10117" href="/d/drug information/10117.html" rel="external">cholecalciferol</a>), and restriction of galactose. Frequent, small meals with adequate caloric intake may improve growth. Treatment with uncooked cornstarch, a complex glucose polymer that is digested over several hours, before bedtime may help maintain glucose levels during sleep [<a href="#rid17">17</a>]. Nocturnal enteral nutrition and/or uncooked cornstarch may normalize growth in a subset of children [<a href="#rid18">18</a>]. Young infants (less than six months) treated with cornstarch may develop gastrointestinal distress (colicky symptoms or diarrhea) since pancreatic amylase has not reached adult levels.</p><p class="headingAnchor" id="H7"><span class="h1">ALDOLASE A DEFICIENCY</span><span class="headingEndMark"> — </span>Aldolase A deficiency (also called glycogen storage disease XII [GSD XII]; MIM #611881) is a rare GSD associated with hereditary hemolytic anemia.</p><p class="headingAnchor" id="H27065237"><span class="h2">Pathogenesis</span><span class="headingEndMark"> — </span>In the glycolytic pathway, three isozymes of aldolase (A, B, and C) are responsible for the conversion of fructose-1,6-biphosphate into glyceraldehyde-3-phosphate and dihydroxyacetone phosphate and are encoded by distinct genes. Aldolase A in humans is encoded by a single gene on chromosome 16p11.2 and is a homotetrameric enzyme [<a href="#rid19">19,20</a>]. Aldolase A is the only isozyme present in both red blood cells and skeletal muscle, but it is also abundantly expressed in the human brain.</p><p class="headingAnchor" id="H8"><span class="h2">Clinical and laboratory findings</span><span class="headingEndMark"> — </span>Only a few patients have been reported with both hemolysis and myopathic symptoms. Five patients developed rhabdomyolysis during a febrile illness [<a href="#rid21">21-25</a>]. Additional manifestations during the acute illness included myopathic symptoms, hemolytic anemia, jaundice, increased ferritin levels, and hyperkalemia. One of these children had initially presented with increasing muscle weakness and transfusion-dependent hemolytic anemia that was reversed following splenectomy [<a href="#rid22">22</a>]. There is also a report of a family with three affected siblings in whom recurrent rhabdomyolysis without hemolytic anemia was observed [<a href="#rid26">26</a>]. Episodes of rhabdomyolysis began in infancy and occurred during febrile illnesses. Mild intellectual disability, short stature, microcephaly, and possibly related dermatologic abnormalities have been reported as well [<a href="#rid21">21,25</a>]. A 23-year-old male was reported with exercise-induced rhabdomyolysis and progressive fixed muscle weakness with mild lordosis, scapula winging, distal hand weakness, and neck flexion weakness and a homozygous thermolabile variant p.Ala280Val [<a href="#rid24">24</a>]. While a forearm ischemia test was normal, electromyography demonstrated small amplitude, short duration polyphasic motor unit action potentials, with early recruitment in both proximal and distal upper and lower limb muscles.</p><p>Laboratory findings in one of the two children first reported included a highly elevated serum creatine kinase and markers of hemolysis, mild hemoglobinuria, and myoglobinuria [<a href="#rid21">21</a>]. Biochemical assays showed a profound reduction in red blood cell and skeletal muscle aldolase A level and also diminished thermostability of the residual enzyme. A third child with suspected hemolytic anemia had associated myopathic symptoms at birth, as well as arthrogryposis multiplex congenita and pituitary ectopia [<a href="#rid23">23</a>]. Another phenotype of aldolase A deficiency has been described in a 14-year-old boy who presented with several episodes of epileptic seizures followed by rhabdomyolysis. In addition to the very high creatine kinase concentrations and transaminases, he also had severe metabolic acidosis and hyperuricemia without hemolytic anemia. Genetic testing showed a homozygous pathogenic variant in the aldolase, fructose-bisphosphate A (<em>ALDOA</em>) gene. This patient had a favorable response to a ketogenic diet in addition to antiseizure medications [<a href="#rid27">27</a>].</p><p>Despite its rare occurrence, a history of hemolytic anemia and the development of myopathic symptoms and/or myoglobinuria in the setting of fever and/or overexertion, which may also elevate core body temperature [<a href="#rid24">24</a>], should alert the clinician to the possibility of aldolase A deficiency. (See  <a class="medical medical_review" href="/d/html/7128.html" rel="external">"Rare RBC enzyme disorders"</a>.)</p><p class="headingAnchor" id="H27065376"><span class="h2">Diagnosis</span><span class="headingEndMark"> — </span>Aldolase A activity is diminished in erythrocytes and muscle biopsy tissue of patients with aldolase A deficiency. Hence, an enzymatic assay has typically been used to make the diagnosis, but this diagnostic approach has been superseded by genomic analysis. The detection of a homozygous pathogenic variant or two heterozygous variants in the <em>ALDOA</em> gene by sequence analysis can confirm the diagnosis.</p><p class="headingAnchor" id="H27065391"><span class="h2">Treatment</span><span class="headingEndMark"> — </span>Treatment of aldolase A deficiency remains supportive. Enzyme replacement therapy is not available. Patients are usually assessed first by a hematologist regarding the diagnosis and management of hemolytic anemia. During febrile episodes, patients with confirmed enzymatic and/or molecular diagnosis should be treated aggressively with antipyretics to diminish the risk of hemolysis and rhabdomyolysis. (See  <a class="medical medical_review" href="/d/html/5932.html" rel="external">"Overview of hemolytic anemias in children", section on 'Enzyme deficiencies'</a>.)</p><p class="headingAnchor" id="H27065406"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features of glycogen storage diseases</strong> – Inborn errors of glycogen metabolism include the inherited glycogen storage diseases (GSDs)  (<a class="graphic graphic_table graphicRef54417" href="/d/graphic/54417.html" rel="external">table 1</a>). The major manifestations of disorders of glycogen metabolism affecting the liver are hypoglycemia and hepatomegaly, and the primary features of those defects that affect muscle are muscle cramps, exercise intolerance and easy fatigability, and progressive weakness. (See <a class="local">'Introduction'</a> above and  <a class="medical medical_review" href="/d/html/2941.html" rel="external">"Overview of inherited disorders of glucose and glycogen metabolism"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Glucose transporter 2 (GLUT2) deficiency</strong> – GLUT2 deficiency, also known as Fanconi-Bickel syndrome, is a rare disorder of glucose homeostasis that leads to accumulation of glycogen in the liver and kidney and glucose and galactose intolerance. Affected patients typically present in infancy with hepatomegaly secondary to glycogen accumulation, severe failure to thrive, renal tubulopathy, and rickets. No specific treatment is available, other than dietary and electrolyte management. (See <a class="local">'GLUT2 deficiency'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Aldolase A deficiency</strong> – Aldolase A deficiency, also called GSD XII, is a rare GSD associated with hereditary hemolytic anemia. The most common findings are myopathic symptoms and hemolytic anemia. Rhabdomyolysis can occur during a febrile illness. Treatment of aldolase A deficiency includes management of hemolytic anemia and antipyretics during febrile episodes to decrease the risk of hemolysis and rhabdomyolysis. (See <a class="local">'Aldolase A deficiency'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Brown GK. Glucose transporters: structure, function and consequences of deficiency. J Inherit Metab Dis 2000; 23:237.</a></li><li><a class="nounderline abstract_t">Kellett GL, Brot-Laroche E, Mace OJ, Leturque A. Sugar absorption in the intestine: the role of GLUT2. Annu Rev Nutr 2008; 28:35.</a></li><li><a class="nounderline abstract_t">Santer R, Schneppenheim R, Dombrowski A, et al. Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome. Nat Genet 1997; 17:324.</a></li><li><a class="nounderline abstract_t">Musa SA, Ibrahim AA, Hassan SS, et al. Fanconi Bickel syndrome: clinical phenotypes and genetics in a cohort of Sudanese children. Int J Pediatr Endocrinol 2020; 2020:21.</a></li><li><a class="nounderline abstract_t">Santer R, Steinmann B, Schaub J. Fanconi-Bickel syndrome--a congenital defect of facilitative glucose transport. Curr Mol Med 2002; 2:213.</a></li><li><a class="nounderline abstract_t">Berry GT, Baker L, Kaplan FS, Witzleben CL. Diabetes-like renal glomerular disease in Fanconi-Bickel syndrome. Pediatr Nephrol 1995; 9:287.</a></li><li><a class="nounderline abstract_t">Manz F, Bickel H, Brodehl J, et al. Fanconi-Bickel syndrome. Pediatr Nephrol 1987; 1:509.</a></li><li><a class="nounderline abstract_t">Sansbury FH, Flanagan SE, Houghton JA, et al. SLC2A2 mutations can cause neonatal diabetes, suggesting GLUT2 may have a role in human insulin secretion. Diabetologia 2012; 55:2381.</a></li><li><a class="nounderline abstract_t">Taha D, Al-Harbi N, Al-Sabban E. Hyperglycemia and hypoinsulinemia in patients with Fanconi-Bickel syndrome. J Pediatr Endocrinol Metab 2008; 21:581.</a></li><li><a class="nounderline abstract_t">Govindarajan S, Khandelwal P, Sharma S, et al. Clinical Features and Genetic Sequencing of Children with Fanconi-Bickel Syndrome. Indian J Pediatr 2023; 90:178.</a></li><li><a class="nounderline abstract_t">Dunger DB, Holder AT, Leonard JV, et al. Growth and endocrine changes in the hepatic glycogenoses. Eur J Pediatr 1982; 138:226.</a></li><li><a class="nounderline abstract_t">Mannstadt M, Magen D, Segawa H, et al. Fanconi-Bickel syndrome and autosomal recessive proximal tubulopathy with hypercalciuria (ARPTH) are allelic variants caused by GLUT2 mutations. J Clin Endocrinol Metab 2012; 97:E1978.</a></li><li><a class="nounderline abstract_t">Pogoriler J, O'Neill AF, Voss SD, et al. Hepatocellular Carcinoma in Fanconi-Bickel Syndrome. Pediatr Dev Pathol 2018; 21:84.</a></li><li><a class="nounderline abstract_t">Sarhan OM, Al Farhan A, Abdallah S, et al. Pediatric metanephric adenoma with Fanconi-Bickel syndrome: a case report and review of literature. Surg Case Rep 2022; 8:86.</a></li><li><a class="nounderline abstract_t">Paesold-Burda P, Baumgartner MR, Santer R, et al. Elevated serum biotinidase activity in hepatic glycogen storage disorders--a convenient biomarker. J Inherit Metab Dis 2007; 30:896.</a></li><li><a class="nounderline abstract_t">Müller D, Santer R, Krawinkel M, et al. Fanconi-Bickel syndrome presenting in neonatal screening for galactosaemia. J Inherit Metab Dis 1997; 20:607.</a></li><li><a class="nounderline abstract_t">Lee PJ, Van't Hoff WG, Leonard JV. Catch-up growth in Fanconi-Bickel syndrome with uncooked cornstarch. J Inherit Metab Dis 1995; 18:153.</a></li><li><a class="nounderline abstract_t">Pennisi A, Maranda B, Benoist JF, et al. Nocturnal enteral nutrition is therapeutic for growth failure in Fanconi-Bickel syndrome. J Inherit Metab Dis 2020; 43:540.</a></li><li><a class="nounderline abstract_t">Kikuta A, Yoshida MC, Sakakibara M, et al. Molecular gene mapping for the structural gene for human aldolase A (ALDOA) to chromosome 22. Cytogenet Cell Genet 1985; 40:674 (Abstract).</a></li><li><a class="nounderline abstract_t">Serero S, Maire P, Nguyen VC, et al. Localization of the active gene of aldolase on chromosome 16, and two aldolase A pseudogenes on chromosomes 3 and 10. Hum Genet 1988; 78:167.</a></li><li><a class="nounderline abstract_t">Kreuder J, Borkhardt A, Repp R, et al. Brief report: inherited metabolic myopathy and hemolysis due to a mutation in aldolase A. N Engl J Med 1996; 334:1100.</a></li><li><a class="nounderline abstract_t">Yao DC, Tolan DR, Murray MF, et al. Hemolytic anemia and severe rhabdomyolysis caused by compound heterozygous mutations of the gene for erythrocyte/muscle isozyme of aldolase, ALDOA(Arg303X/Cys338Tyr). Blood 2004; 103:2401.</a></li><li><a class="nounderline abstract_t">Esposito G, Vitagliano L, Costanzo P, et al. Human aldolase A natural mutants: relationship between flexibility of the C-terminal region and enzyme function. Biochem J 2004; 380:51.</a></li><li><a class="nounderline abstract_t">Papadopoulos C, Svingou M, Kekou K, et al. Aldolase A deficiency: Report of new cases and literature review. Mol Genet Metab Rep 2021; 27:100730.</a></li><li><a class="nounderline abstract_t">Kara E, Kor D, Bulut FD, et al. Glycogen storage disease type XII; an ultra rare cause of hemolytic anemia and rhabdomyolysis: one new case report. J Pediatr Endocrinol Metab 2021; 34:1335.</a></li><li><a class="nounderline abstract_t">Mamoune A, Bahuau M, Hamel Y, et al. A thermolabile aldolase A mutant causes fever-induced recurrent rhabdomyolysis without hemolytic anemia. PLoS Genet 2014; 10:e1004711.</a></li><li><a class="nounderline abstract_t">Santoro L, Pjetraj D, Velmishi V, et al. A new phenotype of aldolase a deficiency in a 14 year-old boy with epilepsy and rhabdomyolysis - case report. Ital J Pediatr 2022; 48:39.</a></li></ol></div><div id="topicVersionRevision">Topic 2914 Version 14.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10863940" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Glucose transporters: structure, function and consequences of deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18393659" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Sugar absorption in the intestine: the role of GLUT2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9354798" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33292488" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Fanconi Bickel syndrome: clinical phenotypes and genetics in a cohort of Sudanese children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11949937" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Fanconi-Bickel syndrome--a congenital defect of facilitative glucose transport.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7632512" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Diabetes-like renal glomerular disease in Fanconi-Bickel syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3153325" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Fanconi-Bickel syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22660720" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : SLC2A2 mutations can cause neonatal diabetes, suggesting GLUT2 may have a role in human insulin secretion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18717244" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Hyperglycemia and hypoinsulinemia in patients with Fanconi-Bickel syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36324017" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Clinical Features and Genetic Sequencing of Children with Fanconi-Bickel Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6749505" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Growth and endocrine changes in the hepatic glycogenoses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22865906" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Fanconi-Bickel syndrome and autosomal recessive proximal tubulopathy with hypercalciuria (ARPTH) are allelic variants caused by GLUT2 mutations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28382841" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Hepatocellular Carcinoma in Fanconi-Bickel Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35511306" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Pediatric metanephric adenoma with Fanconi-Bickel syndrome: a case report and review of literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17994282" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Elevated serum biotinidase activity in hepatic glycogen storage disorders--a convenient biomarker.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9266402" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Fanconi-Bickel syndrome presenting in neonatal screening for galactosaemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7564233" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Catch-up growth in Fanconi-Bickel syndrome with uncooked cornstarch.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31816104" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Nocturnal enteral nutrition is therapeutic for growth failure in Fanconi-Bickel syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Molecular gene mapping for the structural gene for human aldolase A (ALDOA) to chromosome 22</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2828224" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Localization of the active gene of aldolase on chromosome 16, and two aldolase A pseudogenes on chromosomes 3 and 10.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8598869" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Brief report: inherited metabolic myopathy and hemolysis due to a mutation in aldolase A.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14615364" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Hemolytic anemia and severe rhabdomyolysis caused by compound heterozygous mutations of the gene for erythrocyte/muscle isozyme of aldolase, ALDOA(Arg303X/Cys338Tyr).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14766013" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Human aldolase A natural mutants: relationship between flexibility of the C-terminal region and enzyme function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33665120" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Aldolase A deficiency: Report of new cases and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34171939" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Glycogen storage disease type XII; an ultra rare cause of hemolytic anemia and rhabdomyolysis: one new case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25392908" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : A thermolabile aldolase A mutant causes fever-induced recurrent rhabdomyolysis without hemolytic anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35246226" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : A new phenotype of aldolase a deficiency in a 14 year-old boy with epilepsy and rhabdomyolysis - case report.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
